PTCL
Showing 1 - 7 of 7
First-line Maintenance Treatment of PTCL With Chidamide.
Recruiting
- PTCL
-
Nanjing, Jiangsu, ChinaHematological Department, People's Hospital of Jiangsu Province
Jul 23, 2023
Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)
Completed
- Peripheral T Cell Lymphoma
- +18 more
-
Vancouver, British Columbia, Canada
- +29 more
Apr 29, 2022
PTCL Trial (YY-20394 treatment)
Not yet recruiting
- PTCL
- YY-20394 treatment
- (no location specified)
Jan 8, 2021
PTCL, Gemcitabine Trial in Jinan
Unknown status
- PTCL
- Gemcitabine
-
Jinan, Shandong, ChinaYujie MS JIANG
Mar 19, 2019